Combination Chemotherapy and Donor Stem Cell Transplant Followed by Ixazomib Citrate Maintenance Therapy in Treating Patients With Relapsed High-Risk Multiple Myeloma
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)
Texas Oncology Cancer Center
Memorial Sloan Kettering Cancer Center
Barbara Ann Karmanos Cancer Institute
SWOG Cancer Research Network
National Institutes of Health Clinical Center (CC)